Evidence-driven small-molecule discovery
NMI Discovery generates diverse, synthesizable candidates, ranks them with Boltz-2, and reports clear, pose-aware SAR. Built for regulated R&D environments.
Breadth before optimization
Wide search across chemotypes; quotas prevent mode collapse.
Defensible scoring
Boltz-2 primary; adjunct signals documented and optional.
Operational clarity
Pose-aware SAR cards, provenance, and review-ready CSV.
Controlled deployment
On-prem or private cloud. No telemetry. Audit-friendly.